Related Experiment Video
Updated: Dec 23, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Decreased bone mineral density and reproductive axis dysfunction: more than oestrogen
1Mayo Clinic School of Medicine, Mayo Clinic, Rochester Minnesota, USA.
In certain conditions like female athlete triad or anorexia nervosa, low estrogen doesn't solely cause bone density loss. Restoring reproductive function and caloric intake is key for bone health, not estrogen therapy.
Area of Science:
- Endocrinology
- Bone Metabolism
- Sports Medicine
Background:
- Decreased bone mineral density (BMD) is often linked to low estrogen.
- Estrogen replacement typically improves BMD in hypoestrogenic states.
- The efficacy of estrogen replacement for BMD is uncertain in conditions like female athlete triad and anorexia nervosa.
Purpose of the Study:
- To investigate the relationship between estrogen levels and BMD in reproductive axis dysfunction.
- To explore factors beyond estrogen influencing BMD in athletes and individuals with anorexia nervosa.
- To evaluate the effectiveness of estrogen replacement therapy in these specific populations.
Main Methods:
- Review of existing literature on BMD, estrogen deficiency, and reproductive axis dysfunction.
- Analysis of studies involving female athletes and individuals with anorexia nervosa.
- Comparison of BMD outcomes with and without estrogen supplementation in these groups.
Main Results:
- Estrogen deficiency is associated with decreased BMD in reproductive axis dysfunction.
- Estrogen replacement therapy did not consistently improve BMD in female athletes or those with anorexia nervosa.
- Factors beyond estrogen, potentially including cortisol and inflammation, may contribute to BMD loss.
Conclusions:
- Low estrogen is not the sole driver of decreased BMD in reproductive axis dysfunction secondary to energy imbalance.
- Increased caloric intake and restoration of the reproductive axis are crucial for improving BMD.
- Pharmacological estrogen therapy offers no conclusive benefit for BMD in these conditions.
More Related Videos
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Menopause
Oogenesis
Disorders of the Female Reproductive System
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...